Search results
Results from the WOW.Com Content Network
Take for example the Therac-25, a radiation medical device involved in accidents in which patients were given massive overdoses of radiation, due to unverified software control. [ 5 ] The acceptance test determines whether the PACS is ready for clinical use and marks the warranty timeline while serving as a payment milestone.
Emergency Medical Technician - Intermediate (OLD) EMT-P: Emergency Medical Technician - Paramedic (OLD) EN: Enrolled nurse (AU) – See Licensed practical nurse: EORTC: European Organization for Research Treatment in Cancer EpSSG: European paediatric soft tissue sarcoma study group ESRD: End Stage Renal Disease Program
Download as PDF; Printable version; ... a system used in medical imaging to store, retrieve, ... PACs is the plural of PAC; for example:
Past medical history (see also medical history) PSI: Pneumonia severity index: PSP: phenylsulphtalein: PSS: progressive systemic sclerosis (see scleroderma) PSVT: paroxysmal supraventricular tachycardia: PT: prothrombin time physical therapy (physiotherapy) Pt. patient (from Latin patiens, meaning "one who endures" or "one who suffers") PTA
Preanesthetic assessment (also called preanesthesia evaluation, pre-anesthesia checkup (PAC) or simply preanesthesia) is a medical check-up and laboratory investigations done by an anesthesia provider or a registered nurse before an operation, to assess the patient's physical condition and any other medical problems or diseases the patient might have. [1]
An example of a cancer study powered for a combined endpoint is disease-free survival; trial participants experiencing either death or discovery of any recurrence would constitute the endpoint. Overall Treatment Utility is an example of a multidimensional composite endpoint in cancer clinical trials.
A study plan on which all clinical trials are based. The plan is carefully designed to safeguard the health of the participants as well as answer specific research questions. A protocol describes what types of people may participate in the trial; the schedule of tests, procedures, medications, and dosages; and the length of the study.
Longer intervals as determined by the study protocol may also be appropriate. In the case of SD, follow-up measurements must have met the SD criteria at least once after study entry at a minimum interval (in general, not less than 6–8 weeks) that is defined in the study protocol; Duration of overall response